A Review of Integrated Staging Systems for Renal Cell Carcinoma
Malek Meskawi(Université de Montréal), Pierre I. Karakiewicz(Université de Montréal), Paul Perrotte(Université de Montréal), Marco Bianchi(Université de Montréal), Maxine Sun(Université de Montréal), Zhe Tian(Tianjin University), Michael Rink(Marienkrankenhaus Hamburg), Quoc‐Dien Trinh(University of Pittsburgh Medical Center), Shahrokh F. Shariat(Universitätszahnklinik Wien), Jens Hansen(Icahn School of Medicine at Mount Sinai), Francesco Montorsi(Vita-Salute San Raffaele University), Salima Ismail(Université de Montréal)
Cited by 123
Related Papers
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
|Cancer Cell|2021|624
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
|Cancer Cell|2021|515
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471